598 related articles for article (PubMed ID: 9661641)
21. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
[TBL] [Abstract][Full Text] [Related]
22. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
23. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
25. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
DeVito WJ; Stone S
J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
[TBL] [Abstract][Full Text] [Related]
26. Localization and temporal expression of prolactin receptor in human endometrium.
Jones RL; Critchley HO; Brooks J; Jabbour HN; McNeilly AS
J Clin Endocrinol Metab; 1998 Jan; 83(1):258-62. PubMed ID: 9435452
[TBL] [Abstract][Full Text] [Related]
27. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
[TBL] [Abstract][Full Text] [Related]
28. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
29. Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a.
Hewetson A; Moore SL; Chilton BS
Biol Reprod; 2004 Dec; 71(6):1907-12. PubMed ID: 15306550
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
Pezet A; Ferrag F; Kelly PA; Edery M
J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
[TBL] [Abstract][Full Text] [Related]
32. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
[TBL] [Abstract][Full Text] [Related]
33. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
[TBL] [Abstract][Full Text] [Related]
35. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
36. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
37. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
38. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
[TBL] [Abstract][Full Text] [Related]
39. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
[TBL] [Abstract][Full Text] [Related]
40. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
Pezet A; Buteau H; Kelly PA; Edery M
Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]